Celcuity Celcuity
  • Company
    • About Us
    • Leadership
    • Contact
  • Science
    • PAM Pathway
    • Gedatolisib
    • Scientific Publications
  • Medicines
    • REVTORPYK®
    • Patient Advocacy
  • Pipeline
    • Our Pipeline
    • Clinical Trials
    • Expanded Access Program
  • Investors
    • Corporate Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Mangement Team
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • IR Resources
      • Email Alerts
      • Contact IR
  • Careers
    • Our Culture
    • Job Openings
  • Expanded Access Program
Select Page
Celcuity
  • Company
    • About Us
    • Leadership
    • Contact
  • Science
    • PAM Pathway
    • Gedatolisib
    • Scientific Publications
  • Medicines
    • REVTORPYK®
    • Patient Advocacy
  • Pipeline
    • Our Pipeline
    • Clinical Trials
    • Expanded Access Program
  • Investors
    • Corporate Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Mangement Team
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • IR Resources
      • Email Alerts
      • Contact IR
  • Careers
    • Our Culture
    • Job Openings
  • Expanded Access Program

Medicines

Product Website
Prescribing Information
Patient Information
  • Company
  • Science
  • Medicines
  • Pipeline
  • Careers
  • Investors
2800 Campus Drive
Suite 140
Minneapolis, MN 55441
Privacy Center Terms of Use Website by 22 Fillmore
Celcuity-footer
Privacy Center Terms of Use Website by 22 Fillmore
©2026 Celcuity Inc. All Rights Reserved. REVTORPYK and its logo are trademarks of Celcuity Inc.
REVT_TM_Logo_DosAdm_RGB_Blk_Pos 1

We’re proud to announce that REVTORPYK has been approved by the U.S. Food & Drug Administration!

Read Our Press Release
Visit Product Website
Full Prescribing Information
© 2026 Celcuity Inc. All rights reserved. REVTORPYK and its logo are trademarks of Celcuity Inc. US-G1B-26-0242